NCT02073669View on ClinicalTrials.gov

Latent Tuberculosis in Second Generation Immigrants From High Risk Countries Compare to Low-risk Young Israeli Adults

NACompletedINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

August 31, 2018

Study Completion Date

November 30, 2018

Conditions
Latent Tuberculosis
Interventions
PROCEDURE

Answering the study Questionnaire and blood sampling for Interferon gamma release assay (IGRA)

Trial Locations (2)

52621

Sheba Medical Center, Ramat Gan

Unknown

Israeli Defense Forces, Ramat Gan

All Listed Sponsors
collaborator

Tel Aviv Lung Association

OTHER

lead

Sheba Medical Center

OTHER_GOV

NCT02073669 - Latent Tuberculosis in Second Generation Immigrants From High Risk Countries Compare to Low-risk Young Israeli Adults | Biotech Hunter | Biotech Hunter